Results 61 to 70 of about 68,751 (311)

Evaluation of oral health of 6 to 10-year-old asthmatic children receiving bronchodilator through inhaler

Indian Journal of Dental Research, 2019
Aim: The aim of this study was to evaluate the oral health status in 6 to 10-year-old asthmatic children receiving bronchodilator (salbutamol, salmeterol, etc.) through inhaler and compare them with nonasthmatic healthy children. Settings and Design: The
Sudhir Kumar, Namita Kalra, Rishi Tyagi, M M A Faridi, Amit Khatri, V N V Satish   +5 more
doaj   +1 more source

Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study

European Respiratory Journal, 2013
We investigated the efficacy and safety of dual bronchodilation with QVA149 versus its monocomponents indacaterol and glycopyrronium, tiotropium and placebo in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD).
E. Bateman, G. Ferguson, N. Barnes, N. Gallagher, Y. Green, M. Henley, D. Banerji   +6 more
semanticscholar   +1 more source

Evidence‐based guideline for clinical practice in the diagnosis, treatment, management, and prevention of recurrent wheezing in infants and toddlers in China

Pediatric Investigation, EarlyView.
ABSTRACT Wheezing is a common respiratory symptom in infants and toddlers, and recurrent wheezing is a significant respiratory disorder affecting this age group. Given the multifactorial etiology of recurrent wheezing, clinical practice lacks standardized diagnostic and therapeutic protocols. Recent years have witnessed substantial progress in clinical
Committee of Pediatrics, China Medical Education Association, Cooperative Group of Asthma, the Subspecialty Group of Respiratory, the Society of Pediatrics, Chinese Medical Association, Pediatric Respiratory Work Committee, Society of Pulmonologists, Chinese Medical Doctor Association, Committee of Pediatrics, Chinese Research Hospital Association, Pediatric Professional Committee of the Chinese Non‐public Medical Institutions Association, Professional Committee of Children's Health and Pharmaceutical Research, China Association of Traditional Chinese Medicine, Children's Safe Medication Branch of China News of Drug Information Association, Pediatric Expert Committee of China Primary Health Care Foundation, China International Medical Foundation   +16 more
wiley   +1 more source

Allergic Reaction to Aminophylline in a Case of Lower Respiratory Tract Infection with Measles: A Rare Case Report [PDF]

Journal of Clinical and Diagnostic Research
Measles is an acute respiratory infectious disease caused by the measles virus. It leads to respiratory involvement with manifestations such as pneumonia, laryngobronchitis, pneumonitis, etc.
Anuja Satish Handargule, Amar Taksande, Revat Meshram, poonam uke   +3 more
doaj   +1 more source

Inhaled Bronchodilator Use for Infants with Bronchopulmonary Dysplasia

Journal of Perinatology, 2014
Objective:To identify factors associated with bronchodilator administration to infants with bronchopulmonary dysplasia (BPD) and evaluate inter-institutional prescribing patterns.Study Design:A retrospective cohort study of
J. Slaughter, M. Stenger, Patricia B. Reagan, S. Jadcherla   +3 more
semanticscholar   +1 more source

Anti‐Allergic Potential of Chamaecrista nomame and Its Compound Luteolin for Novel Asthma Therapy

Phytotherapy Research, EarlyView.
Chamaecrista nomame (CN) and its active compound luteolin attenuate allergic airway inflammation by inhibiting mast cell activation and suppressing NF‐κB/MAPK signaling, leading to reduced cytokine production and OVA‐specific IgE levels. ABSTRACT Asthma is a chronic inflammatory disease driven by dysregulated immune responses and mast cell activation ...
Tae Kyeom Kang, Myungsuk Kim, Tam Thi Le, Geon Park, Yuna Jung, Hyobin Jeong, Youngsang Yoo, Wook‐Bin Lee, Sang Hoon Jung   +8 more
wiley   +1 more source

Pharmacological therapy for stable chronic obstructive pulmonary disease

Chronic Diseases and Translational Medicine, 2023
In recent years, emphasis has shifted from preventing and treating chronic obstructive pulmonary disease (COPD) to early prevention, early treatment, and disease stabilization, with the main goal of improving patients’ quality of life and reducing the ...
Ruirui Duan, Baicun Li, Ting Yang
doaj   +1 more source

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

, 2009
Background: The efficacy of inhaled salmeterol plus fluticasone propionate (SFC) in patients with severe or very severe COPD is well documented. However, there are only limited data about the influence of GOLD severity staging on the effectiveness of ...
Jones, Paul W, Yates, Julie C, Jones, PW, Yates Julie C, Vestbo Jörgen, Jenkins, Christine R, Willits, LR, Celli Bartolome, Willits Lisa R, Anderson, Julie A., Calverley, PMA, Calverley, PM, Willits, Lisa R., Julie A Anderson, Jörgen Vestbo, Anderson Julie A, Yates, JC, Calverley Peter MA, Anderson, JA, Vestbo, Jörgen, Jones Paul W, Ferguson Gary T, Christine R Jenkins, Jenkins, CR, Ferguson, GT, Gary T Ferguson, Anderson, Julie A, Vestbo, Jorgen; id_orcid, Celli, Bartolome, Bartolome Celli, Peter MA Calverley, Lisa R Willits, Ferguson, Gary T., Calverley, Peter M A, Ferguson, Gary T, Vestbo, J, Jenkins Christine R, Jenkins, CR ; https://orcid.org/, Celli, B, Paul W Jones, Jones, Paul W., Jenkins, Christine R., Julie C Yates, Willits, Lisa R, Yates, Julie C.   +44 more
core   +1 more source

Clinical characteristics of immediate allergic adverse reactions to intravenous amoxicillin‒clavulanic acid in conscious dogs

Veterinary Record, EarlyView.
Abstract Background Amoxicillin‒clavulanic acid (AMC) is one of the most frequently used antibiotics in small animal practice, and reports on adverse reactions are scarce. The aim of this study was to describe the clinical characteristics of immediate allergic adverse reactions to intravenous (IV) AMC in conscious dogs. Methods The medical records of a
Leonel Frutuoso, Anna Threlfall
wiley   +1 more source

Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD

International Journal of COPD, 2019
James F Donohue,1 Donald A Mahler,2,3 Sanjay Sethi4 1Pulmonary Medicine, UNC School of Medicine, Chapel Hill, NC, USA; 2Geisel School of Medicine at Dartmouth, Hanover, NH, USA; 3Director of Respiratory Services, Valley Regional Hospital, Claremont, NH ...
Donohue JF, Mahler DA, Sethi S
doaj